Sagicor Financial Company Ltd.

BST:3RQ Stock Report

Market Cap: €566.5m

Sagicor Financial Valuation

Is 3RQ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

6/6

Valuation Score 6/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of 3RQ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 3RQ (€4.08) is trading below our estimate of fair value (€7.24)

Significantly Below Fair Value: 3RQ is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for 3RQ?

Key metric: As 3RQ is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 3RQ. This is calculated by dividing 3RQ's market cap by their current earnings.
What is 3RQ's PE Ratio?
PE Ratio1.2x
EarningsUS$530.40m
Market CapUS$600.21m

Price to Earnings Ratio vs Peers

How does 3RQ's PE Ratio compare to its peers?

The above table shows the PE ratio for 3RQ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average18.8x
WUW Wüstenrot & Württembergische
26.3x34.6%€1.1b
NBG6 NÜRNBERGER Beteiligungs-AG
14.4x38.4%€599.0m
RLV RheinLand Holding
12.5xn/a€112.9m
DFV DFV Deutsche Familienversicherung
22.1xn/a€95.5m
3RQ Sagicor Financial
1.2x-95.3%€838.1m

Price-To-Earnings vs Peers: 3RQ is good value based on its Price-To-Earnings Ratio (1.2x) compared to the peer average (18.8x).


Price to Earnings Ratio vs Industry

How does 3RQ's PE Ratio compare vs other companies in the European Insurance Industry?

2 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.11.7x5.2%
3RQ Sagicor Financial
1.2x-95.3%US$600.21m
3RQ 1.2xIndustry Avg. 11.7xNo. of Companies12PE0816243240+
2 CompaniesEstimated GrowthMarket Cap
Industry Avg.11.7x5.2%
3RQ Sagicor Financial
1.2x-95.3%US$600.21m
No more companies

Price-To-Earnings vs Industry: 3RQ is good value based on its Price-To-Earnings Ratio (1.2x) compared to the European Insurance industry average (11.8x).


Price to Earnings Ratio vs Fair Ratio

What is 3RQ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

3RQ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio1.2x
Fair PE Ratio1.3x

Price-To-Earnings vs Fair Ratio: 3RQ is good value based on its Price-To-Earnings Ratio (1.2x) compared to the estimated Fair Price-To-Earnings Ratio (1.3x).


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 3RQ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€4.08
€6.18
+51.4%
6.8%€6.74€5.73n/a3
Nov ’25€4.02
€5.78
+43.7%
5.4%€6.00€5.33n/a3
Oct ’25€3.68
€5.73
+55.8%
5.4%€5.95€5.29n/a3
Sep ’25€3.92
€5.73
+46.3%
5.4%€5.95€5.29n/a3
Aug ’25€3.90
€6.19
+58.7%
6.8%€6.75€5.74n/a3
Jul ’25€4.22
€6.24
+47.8%
6.8%€6.80€5.78n/a3
Jun ’25€4.36
€6.19
+42.1%
6.8%€6.76€5.74n/a3
May ’25€4.36
€6.26
+43.5%
6.8%€6.83€5.80n/a3
Apr ’25€4.68
€6.05
+29.2%
9.6%€6.85€5.48n/a3
Mar ’25€4.40
€6.05
+37.4%
9.6%€6.85€5.48n/a3
Feb ’25€4.14
€6.05
+46.1%
9.6%€6.85€5.48n/a3
Jan ’25€3.92
€5.83
+48.7%
14.4%€6.86€4.80n/a3
Dec ’24€3.98
€5.62
+41.1%
15.0%€6.74€4.72n/a3
Nov ’24€3.60
€5.76
+60.0%
15.0%€6.91€4.84€4.023
Oct ’24€3.42
€6.12
+78.8%
11.1%€6.79€5.44€3.682
Sep ’24€2.88
€6.12
+112.3%
11.1%€6.79€5.44€3.922
Aug ’24€2.84
€5.48
+93.0%
25.0%€6.85€4.11€3.902
Jul ’24€2.90
€5.56
+91.8%
25.0%€6.95€4.17€4.222
Jun ’24€3.30
€5.49
+66.2%
25.0%€6.86€4.11€4.362
May ’24€3.32
€6.10
+83.8%
11.1%€6.78€5.42€4.362
Apr ’24€3.22
€6.10
+89.5%
11.1%€6.78€5.42€4.682
Mar ’24€3.26
€5.96
+83.0%
17.6%€7.02€4.91€4.402
Feb ’24€3.34
€5.88
+75.9%
17.6%€6.91€4.84€4.142
Jan ’24€3.66
€6.15
+68.1%
17.6%€7.24€5.07€3.922
Dec ’23€4.00
€6.15
+53.8%
17.6%€7.24€5.07€3.982
Nov ’23€4.38
€6.68
+52.5%
11.1%€7.42€5.94€3.602

Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.


Discover undervalued companies